White Paper

A Novel Approach to Early Phase Studies for Advanced Therapeutics

Screening & Recruiting Rare Disease Participants

Read more

Have questions about how to conduct an early phase study in a patient population? You aren’t alone. Since our recent completion of an early phase study with rare disease patients, we have had numerous sponsors reach out to ask just that–“how did you do it?” So, we wrote a white paper.

Find out everything you need to know to run a successful Phase I patient study in this whitepaper.

Authors:

Chief Medical and Scientific Officer
Executive Director, Therapeutic Strategy Lead, Rare Diseases

Want to learn more about Worldwide Clinical Trials?